CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 145 enrolled
Drug / intervention
levofloxacin +2 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01096849
NCT01096849Phase 2Completed
CompareCT.gov

A Double-blind, Randomized, Comparator-controlled Study to Assess the Safety, Efficacy, and Pharmacokinetics of ACHN-490 Injection Administered IV in Patients With Complicated Urinary Tract Infections or Acute Pyelonephritis

Achaogen, Inc.·interventional·Posted Mar 31, 2010·Updated Aug 22, 2018

In Brief

A Phase 2 clinical trial evaluating levofloxacin, plazomicin, and 1 other intervention for Complicated Urinary Tract Infection and Acute Pyelonephritis. Completed, enrolled 145 participants.

Detailed Summary

This was a multi-center, multi-national, double-blind, randomized, comparator-controlled study of plazomicin administered intravenously compared with levofloxacin, a standard approved intravenous therapy for complicated urinary tract infection (cUTI) and acute pyelonephritis (AP).

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsComplicated Urinary Tract Infection, Acute Pyelonephritis
Countries--
Collaborators--

Timeline

Phase 2CompletedFinished
20102011201220132014201520162017201820192020202120222023202420252026
First PostedMar 31, 2010
Enrollment StartJul 13, 2010
Primary CompletionApr 3, 2012
TodayJul 2, 2026
Enrollment to primary: 1.7 yearsPosted 16.3 years ago

Interventions

levofloxacindrug

plazomicindrug

placebodrug